Liberty Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Liberty Wealth Management's DGX Position: Q4 2021 in Review
Liberty Wealth Management sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 24 shares — an estimated $4K sold.
Liberty Wealth Management first reported a position in DGX in Q1 2019 and held it in 11 quarters. The position peaked at $36K in Q1 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.
- Liberty Wealth Management reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
- Liberty Wealth Management sold 24 Quest Diagnostics shares in Q4 2021, an estimated $4K.
- Liberty Wealth Management first reported a position in Quest Diagnostics in Q1 2019 and held it in 11 quarters.
- Liberty Wealth Management's Quest Diagnostics position peaked at $36K in Q1 2021.
- 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.
Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.